Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Pediatrics|March 19, 2008
Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virusJulia B Purdy, Rachel I Gafni, James C Reynolds, et al.
American Journal of Public Health|June 6, 2019
Disparities in HIV Viral Suppression Among Adolescents and Young Adults by Perinatal InfectionKunjal Patel, George R Seage, Sandra K Burchett, et al.
Frontiers in Immunology|June 1, 2016
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral DrugsRussell B Van Dyke, Ellen Gould Chadwick, Rohan Hazra, et al.
AIDS (London, England)|December 22, 2022
Cancer risk among HIV-exposed uninfected children in the United StatesMarie-Josèphe Horner, Rohan Hazra, Jill S Barnholtz-Sloan, et al.
Clinical Pediatrics|August 27, 2011
Family functioning and coping styles in families of children with cancer and HIV diseaseStaci Martin, Sarah K Calabrese, Pamela L Wolters, et al.
Developmental Neuropsychology|September 26, 2006
Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART)Staci C Martin, Pamela L Wolters, Mary Anne Toledo-Tamula, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for AgeJane C Lindsey, Denise L Jacobson, Hans M Spiegel, et al.
Analytical Chemistry|December 22, 2012
Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconiumSarah K Himes, Karl B Scheidweiler, Katherine Tassiopoulos, et al.
AIDS Patient Care and Stds|October 23, 2018
Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015Paige L Williams, Yanling Huo, Richard Rutstein, et al.
Metabolism: Clinical and Experimental|October 16, 2010
Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhoodDavid Dimock, Vijaya Thomas, Anna Cushing, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Pediatrics|March 19, 2008
Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virusJulia B Purdy, Rachel I Gafni, James C Reynolds, et al.
American Journal of Public Health|June 6, 2019
Disparities in HIV Viral Suppression Among Adolescents and Young Adults by Perinatal InfectionKunjal Patel, George R Seage, Sandra K Burchett, et al.
Frontiers in Immunology|June 1, 2016
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral DrugsRussell B Van Dyke, Ellen Gould Chadwick, Rohan Hazra, et al.
AIDS (London, England)|December 22, 2022
Cancer risk among HIV-exposed uninfected children in the United StatesMarie-Josèphe Horner, Rohan Hazra, Jill S Barnholtz-Sloan, et al.
Clinical Pediatrics|August 27, 2011
Family functioning and coping styles in families of children with cancer and HIV diseaseStaci Martin, Sarah K Calabrese, Pamela L Wolters, et al.
Developmental Neuropsychology|September 26, 2006
Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART)Staci C Martin, Pamela L Wolters, Mary Anne Toledo-Tamula, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 26, 2020
Safety and Efficacy of 48 and 96 Weeks of Alendronate in Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection and Low Bone Mineral Density for AgeJane C Lindsey, Denise L Jacobson, Hans M Spiegel, et al.
Analytical Chemistry|December 22, 2012
Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconiumSarah K Himes, Karl B Scheidweiler, Katherine Tassiopoulos, et al.
AIDS Patient Care and Stds|October 23, 2018
Trends in Neonatal Prophylaxis and Predictors of Combination Antiretroviral Prophylaxis in US Infants from 1990 to 2015Paige L Williams, Yanling Huo, Richard Rutstein, et al.
Metabolism: Clinical and Experimental|October 16, 2010
Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhoodDavid Dimock, Vijaya Thomas, Anna Cushing, et al.
Pageof 15